Search results
30 gru 2020 · The Coronavirus Efficacy (COVE) phase 3 trial was launched in late July 2020 to assess the safety and efficacy of the mRNA-1273 vaccine in preventing SARS-CoV-2 infection.
- Perspective Vaccine Innovations — Past and Future J.L. Gerberding and B.F. Haynes
New and reemerging pathogens, such as SARS-CoV-2 and new...
- Editorial a New Vaccine to Battle Covid-19 B.F. Haynes
Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety...
- Interactive Medical Case a Treacherous Course J. Little and Others
This interactive feature describes a man who presented to...
- Images in Clinical Medicine Ochronosis B. Di Matteo and M. Marcacci
A 63-year-old man with alkaptonuria was admitted for right...
- Perspective Learning About End-of-Life Care From Grandpa S.D. Halpern
Experience with his 103-year-old grandfather teaches a...
- Editorial Which Genes for Hereditary Breast Cancer S.A. Narod
The study by Dorling et al. 1 included 34 genes and 113,000...
- Editorial Reviewers for The Journal July–December 2020 E.J. Rubin
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine....
- Clinical Problem-Solving Hunting for a Diagnosis N. Houchens and Others
A 47-year-old man in Michigan presented to the ED with a...
- Perspective Vaccine Innovations — Past and Future J.L. Gerberding and B.F. Haynes
The SARS-CoV-2 virus is responsible for the COVID-19 pandemic that has infected hundreds of millions and resulted in millions of deaths worldwide. 1 In the majority of the patients, SARS-CoV-2 presents as a respiratory infection causing fever, chills, cough, difficulty breathing, and other associated symptoms. 2, 3 Serious COVID-19 infection res...
26 lut 2024 · The current body of evidence has reported that patients with SARS-CoV-2 infection may incur a greater risk of acute and post-acute health consequences involving multiple organ systems and...
What is WHO doing to monitor and understand the impact of virus variants on the efficacy of COVID-19 vaccines? WHO has been tracking mutations and variants since the start of the COVID-19 outbreak. Our global SARS-CoV-2 laboratory network includes a dedicated Virus Evolution Working Group, which aims to detect new changes quickly and assess ...
9 lis 2021 · Introduction. A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), initiated the coronavirus disease 2019 (COVID-19) pandemic in 2019 1, 2, 3, 4. The global...
According to the World Health Organization (WHO), as of September 17, 2020, 36 vaccine candidates were under clinical evaluation to treat COVID-19, and 146 candidate vaccines were in preclinical evaluation. Given that vaccines can be applied for prophylaxis and the treatment for SARS-CoV-2 infection, in this review, we introduce the recent ...
23 cze 2021 · Summary. Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some...
